Literature DB >> 15194755

Complete DNA sequence analyses of the first two varicella-zoster virus glycoprotein E (D150N) mutant viruses found in North America: evolution of genotypes with an accelerated cell spread phenotype.

Charles Grose1, Shaun Tyler, Geoff Peters, Joanne Hiebert, Gwen M Stephens, William T Ruyechan, Wallen Jackson, Johnathan Storlie, Graham A Tipples.   

Abstract

Varicella-zoster virus (VZV) is considered to be one of the most genetically stable of all the herpesviruses. Yet two VZV strains with a D150N missense mutation within the gE glycoprotein were isolated in North America in 1998 and 2002. The mutant strains have an accelerated cell spread phenotype, which distinguishes them from all wild-type and laboratory viruses. Since the VZV genome contains 70 additional open reading frames (ORFs), the possibility existed that the phenotypic change was actually due to an as-yet-undiscovered mutation or deletion elsewhere in the genome. To exclude this hypothesis, the entire genomes of the two mutant viruses were sequenced and found to contain 124,883 (VZV-MSP) and 125,459 (VZV-BC) nucleotides. Coding single-nucleotide polymorphisms (SNPs) were identified in 14 ORFs. One missense mutation was discovered in gH, but none was found in gB, gI, gL, or gK. There were no coding SNPs in the major regulatory protein ORF 62. One polymorphism was discovered which could never have been anticipated based on current knowledge of herpesvirus genomics, namely, the origins of replication differed from those in the prototype strain but not in a manner expected to affect cell spread. When the two complete mutant VZV sequences were surveyed in their entirety, the most reasonable conclusion was that the increased cell spread phenotype was dependent substantially or solely on the single D150N polymorphism in glycoprotein gE. The genomic results also expanded the evolutionary database by identifying which VZV ORFs were more likely to mutate over time.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194755      PMCID: PMC421634          DOI: 10.1128/JVI.78.13.6799-6807.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  Cellular factors and IE62 activation of VZV promoters.

Authors:  William T Ruyechan; Hua Peng; Min Yang; John Hay
Journal:  J Med Virol       Date:  2003       Impact factor: 2.327

2.  Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus.

Authors:  Yasuyuki Gomi; Hiroki Sunamachi; Yasuko Mori; Kazuhiro Nagaike; Michiaki Takahashi; Koichi Yamanishi
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Phenotypic and genetic characterization of thymidine kinase from clinical strains of varicella-zoster virus resistant to acyclovir.

Authors:  F Morfin; D Thouvenot; M De Turenne-Tessier; B Lina; M Aymard; T Ooka
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

4.  Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome.

Authors:  K Hsiao; H F Baker; T J Crow; M Poulter; F Owen; J D Terwilliger; D Westaway; J Ott; S B Prusiner
Journal:  Nature       Date:  1989-03-23       Impact factor: 49.962

5.  The out of Africa model of varicella-zoster virus evolution: single nucleotide polymorphisms and private alleles distinguish Asian clades from European/North American clades.

Authors:  Timothy R Wagenaar; Vincent T K Chow; Chantanee Buranathai; Pranee Thawatsupha; Charles Grose
Journal:  Vaccine       Date:  2003-03-07       Impact factor: 3.641

Review 6.  Membrane fusion mediated by herpesvirus glycoproteins: the paradigm of varicella-zoster virus.

Authors:  Nancy L Cole; Charles Grose
Journal:  Rev Med Virol       Date:  2003 Jul-Aug       Impact factor: 6.989

7.  Strain variation of R5 direct repeats in the right-hand portion of the long unique segment of varicella-zoster virus DNA.

Authors:  R Hondo; Y Yogo
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

8.  Promoter sequences of varicella-zoster virus glycoprotein I targeted by cellular transactivating factors Sp1 and USF determine virulence in skin and T cells in SCIDhu mice in vivo.

Authors:  Hideki Ito; Marvin H Sommer; Leigh Zerboni; Hongying He; Dwayne Boucaud; John Hay; William Ruyechan; Ann M Arvin
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

9.  A leucine-to-proline mutation in the insulin receptor in a family with insulin resistance.

Authors:  M P Klinkhamer; N A Groen; G C van der Zon; D Lindhout; L A Sandkuyl; H M Krans; W Möller; J A Maassen
Journal:  EMBO J       Date:  1989-09       Impact factor: 11.598

10.  New variant of varicella-zoster virus.

Authors:  Graham A Tipples; Gwen M Stephens; Chris Sherlock; Margrit Bowler; Benny Hoy; Darrel Cook; Charles Grose
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

View more
  29 in total

1.  A sequence within the varicella-zoster virus (VZV) OriS is a negative regulator of DNA replication and is bound by a protein complex containing the VZV ORF29 protein.

Authors:  Mohamed I Khalil; Ann Arvin; Jeremy Jones; William T Ruyechan
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  Herpesvirus systematics.

Authors:  Andrew J Davison
Journal:  Vet Microbiol       Date:  2010-02-11       Impact factor: 3.293

3.  Essential functions of the unique N-terminal region of the varicella-zoster virus glycoprotein E ectodomain in viral replication and in the pathogenesis of skin infection.

Authors:  Barbara Berarducci; Minako Ikoma; Shaye Stamatis; Marvin Sommer; Charles Grose; Ann M Arvin
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  A full-genome phylogenetic analysis of varicella-zoster virus reveals a novel origin of replication-based genotyping scheme and evidence of recombination between major circulating clades.

Authors:  Geoffrey A Peters; Shaun D Tyler; Charles Grose; Alberto Severini; Michael J Gray; Chris Upton; Graham A Tipples
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

5.  Complete-genome phylogenetic approach to varicella-zoster virus evolution: genetic divergence and evidence for recombination.

Authors:  Peter Norberg; Jan-Ake Liljeqvist; Tomas Bergström; Scott Sammons; D Scott Schmid; Vladimir N Loparev
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

6.  Delayed biosynthesis of varicella-zoster virus glycoprotein C: upregulation by hexamethylene bisacetamide and retinoic acid treatment of infected cells.

Authors:  Johnathan Storlie; Wallen Jackson; Jennifer Hutchinson; Charles Grose
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

7.  Varicella-zoster vaccine virus: evolution in action.

Authors:  Jeffrey I Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-21       Impact factor: 11.205

8.  Complete DNA sequences of two oka strain varicella-zoster virus genomes.

Authors:  Sueli L Tillieux; Wendy S Halsey; Elizabeth S Thomas; John J Voycik; Ganesh M Sathe; Ventzislav Vassilev
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

9.  Insulin-degrading enzyme binds to the nonglycosylated precursor of varicella-zoster virus gE protein found in the endoplasmic reticulum.

Authors:  J E Carpenter; W Jackson; G A de Souza; L Haarr; C Grose
Journal:  J Virol       Date:  2009-10-28       Impact factor: 5.103

Review 10.  A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry, 24-25 July 2008.

Authors:  Judith Breuer; Charles Grose; Peter Norberg; Graham Tipples; D Scott Schmid
Journal:  J Gen Virol       Date:  2010-01-13       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.